A novel immunomodulatory strategy of targeting glyco-immune checkpoints with EAGLE technology

被引：0
|
作者：
Peng, Li [1 ]
机构：
[1] Palleon Pharmaceut, Waltham, MA USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-B034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B034
引用
收藏
页数：2
相关论文
共 31 条
  • [21] Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system
    Ke Ma
    Xiao-Xiao Han
    Xiao-Ming Yang
    Song-Lin Zhou
    Neural Regeneration Research, 2021, 16 (10) : 1944 - 1949
  • [22] Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system
    Ma, Ke
    Han, Xiao-Xiao
    Yang, Xiao-Ming
    Zhou, Song-Lin
    NEURAL REGENERATION RESEARCH, 2021, 16 (10) : 1944 - 1949
  • [23] Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation
    Ahmed, Sultan
    Raqib, Rubhana
    Gudmundsson, Gudmundur Hrafn
    Bergman, Peter
    Agerberth, Birgitta
    Rekha, Rokeya Sultana
    ANTIBIOTICS-BASEL, 2020, 9 (01):
  • [24] Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
    Eskandarian Boroujeni, Mahdi
    Sekrecka, Agata
    Antonczyk, Aleksandra
    Hassani, Sanaz
    Sekrecki, Michal
    Nowicka, Hanna
    Lopacinska, Natalia
    Olya, Arta
    Kluzek, Katarzyna
    Wesoly, Joanna
    Bluyssen, Hans A. R.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma
    Assal, Reem A.
    Elemam, Noha M.
    Mekky, Radwa Y.
    Attia, Abdelrahman A.
    Soliman, Aya Hesham
    Gomaa, Asmaa Ibrahim
    Efthimiadou, Eleni K.
    Braoudaki, Maria
    Fahmy, Sherif Ashraf
    Youness, Rana A.
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [26] Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy
    Aldhamen, Yasser A.
    Seregin, Sergey S.
    Aylsworth, Charles F.
    Godbehere, Sarah
    Amalfitano, Andrea
    INTERNATIONAL IMMUNOLOGY, 2014, 26 (05) : 291 - +
  • [27] Targeting TNF alpha as a novel strategy to enhance CD8+ T cell-dependent immune response in melanoma?
    Bertrand, Florie
    Rochotte, Julia
    Colacios, Celine
    Montfort, Anne
    Andrieu-Abadie, Nathalie
    Levade, Thierry
    Benoist, Herve
    Segui, Bruno
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [28] Development of Dual Receptor Enhanced Pre-Targeting Strategy-A Novel Promising Technology for Immuno-Positron Emission Tomography Imaging
    Sun, Lingyi
    Gai, Yongkang
    Li, Zhonghan
    Zhang, Xiaohui
    Li, Jianchun
    Ma, Yongyong
    Li, Huiqiang
    Barajas, Ramon J.
    Zeng, Dexing
    ADVANCED THERAPEUTICS, 2021, 4 (10)
  • [29] Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
    Prodeus, Aaron
    Abdul-Wahid, Aws
    Fischer, Nicholas W.
    Huang, Eric H-B
    Cydzik, Marzena
    Gariepy, Jean
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : e237
  • [30] Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer
    Saaoud, Fatma
    Lu, Yifan
    Xu, Keman
    Shao, Ying
    Pratico, Domenico
    Vazquez-Padron, Roberto I.
    Wang, Hong
    Yang, Xiaofeng
    PHARMACOLOGY & THERAPEUTICS, 2024, 255
1234